Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
The FDA has approved the first insulin pump – glucose monitor combination of devices which can recommend treatment decisions without the need for a finger-prick blood test.
Tandem Diabetes’ t:slim X2 Insulin Pump has received FDA approval for use alongside Dexcom’s G5 Mobile continuous glucose monitoring (CGM) technology.
The approval is part of a rapid evolution in insulin management, with digitisation and automation gathering pace.
On its own, the t:slim X2 Insulin Pump is one of the smallest insulin pumps on the market and features the firm’s proprietary Micro-Delivery Technology – a method of minuscule insulin delivery claimed to be safer than traditional insulin pumps.
https://pharmaphorum.com/news/fda-tandem-dexcom/
Tandem Diabetes’ t:slim X2 Insulin Pump has received FDA approval for use alongside Dexcom’s G5 Mobile continuous glucose monitoring (CGM) technology.
The approval is part of a rapid evolution in insulin management, with digitisation and automation gathering pace.
On its own, the t:slim X2 Insulin Pump is one of the smallest insulin pumps on the market and features the firm’s proprietary Micro-Delivery Technology – a method of minuscule insulin delivery claimed to be safer than traditional insulin pumps.
https://pharmaphorum.com/news/fda-tandem-dexcom/